Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Aleksandra Atanasova Boshku"'
Publikováno v:
EJIFCC. 33(2)
Widespread vaccination is considered as one of the best methods in combating any pandemic including COVID-19. Gam-COVID-Vac also known as Sputnik V, is one of the first vaccines that was registered in 74 countries and received an emergency approval f
Autor:
Aleksandra Atanasova-Boshku, Viktorija Jovanovska, Vesna Livrinova, Igor Petrov, Igor Samardziski, Milena Gjorgjievska, Irena Todorovska, Slagjana Simeonova-Krstevska
Publikováno v:
Open Access Macedonian Journal of Medical Sciences, Vol 6, Iss 6, Pp 1028-1031 (2018)
Open Access Macedonian Journal of Medical Sciences
Open Access Macedonian Journal of Medical Sciences; Vol 6, No 6 (2018): Jun 20 (OAMJMS); 1028-1031
Open Access Macedonian Journal of Medical Sciences; Vol 6 No 6 (2018): Jun 20 (OAMJMS); 1028-1031
Open Access Macedonian Journal of Medical Sciences
Open Access Macedonian Journal of Medical Sciences; Vol 6, No 6 (2018): Jun 20 (OAMJMS); 1028-1031
Open Access Macedonian Journal of Medical Sciences; Vol 6 No 6 (2018): Jun 20 (OAMJMS); 1028-1031
BACKGROUND: Pregnancy-associated plasma protein A (PAPP-A), is a protease which releases Insulin-like growth factor. The role of this factor is stimulation of cell mitosis, differentiation and trophoblastic invasion of deciduas. Identification of pat
Autor:
Viktorija Jovanovska, Irena Todorovska, Ajla Shabani, Aleksandra Atanasova Boshku, Drage Dabeski, Vesna Livrinova, Igor Petrov, Igor Samardziski
Publikováno v:
Open Access Macedonian Journal of Medical Sciences; Vol. 7 No. 9 (2019): May 15 (OAMJMS); 1475-1479
Open Access Macedonian Journal of Medical Sciences
Open Access Macedonian Journal of Medical Sciences, Vol 7, Iss 9 (2019)
Open Access Macedonian Journal of Medical Sciences
Open Access Macedonian Journal of Medical Sciences, Vol 7, Iss 9 (2019)
BACKGROUND: A variety of recent evidence exists about the clinical implication of low level of Pregnancy-associated plasma protein A (PAPP-A) in pregnancy. This glycoprotein is a protease, which releases the Insulin-like growth factor from IGFBP 4. I
Publikováno v:
Metabolism. 116:154589
Autor:
Aleksandra Atanasova Boshku, Sasha Jovanovska Mishevska, Beti Zafirova Ivanovska, Daniela Ivanova Panova
Publikováno v:
Endocrine Oncology and Metabolism, Vol 2, Iss 4, Pp 242-249 (2016)
Obesity and insulin resistance are frequently seen comorbidities in patients with polycystic ovary syndrome (PCOS), affecting the already disturbed metabolism of these patients. Disturbed secretion of adiponectin and leptin could be one of the contri
Autor:
Aleksandra Atanasova-Boshku, Tatjana Milenkovic, Biljana Todorova, Sasha Jovanovska-Mishevska, Iskra Bitoska, Irfan Ahmeti, Gordana Pemovska, Brankica Krstevska
Publikováno v:
Open Access Macedonian Journal of Medical Sciences
Open Access Macedonian Journal of Medical Sciences; Vol 4, No 4 (2016): Dec 15 (OAMJMS); 607-612
Open Access Macedonian Journal of Medical Sciences; Vol. 4 No. 4 (2016): Dec 15 (OAMJMS); 607-612
Open Access Macedonian Journal of Medical Sciences, Vol 4, Iss 4, Pp 607-612 (2016)
Open Access Macedonian Journal of Medical Sciences; Vol 4, No 4 (2016): Dec 15 (OAMJMS); 607-612
Open Access Macedonian Journal of Medical Sciences; Vol. 4 No. 4 (2016): Dec 15 (OAMJMS); 607-612
Open Access Macedonian Journal of Medical Sciences, Vol 4, Iss 4, Pp 607-612 (2016)
BACKGROUND: Polycystic ovary syndrome (PCOS) is complex hormonal, metabolic and reproductive disorder and is a leading cause of female infertility. Hyperinsulinemia secondary to insulin resistance plays important role in the pathogenesis of PCOS.AIM:
Autor:
Sasha Jovanovska Mishevska, Brankica Krstevska, Gordana Pemovska, Tatjana Milenkovic, Iskra Bitoska, Aleksandra Atanasova Boshku
Publikováno v:
Endocrine Oncology and Metabolism, Vol 2, Iss 2, Pp 94-101 (2016)
Polycystic ovary syndrome (PCOS) is one of the most frequent endocrine disorders in women of reproductive age, characterized by the association of polycystic ovaries, hyperandrogenism and chronic anovulation. Excessive ovarian production of anti- mü
Publikováno v:
Atherosclerosis. 263:e250-e251
Publikováno v:
Atherosclerosis Supplements. 32:46